ALM.MC Shariah Compliance
Screening Methodology: AAOIFI
UNLOCK FOR FREE
Last Updated: March 15, 2025
Report Source: 2024 2nd Quarter Report
Almirall SA. Stock Analysis ALM.MC
Almirall SA is a global biopharmaceutical company, which is focused on skin health. The company is headquartered in Barcelona, Barcelona and currently employs 2,026 full-time employees. The company went IPO on 2007-04-19. The firm focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The firm's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The firm operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Read More Almirall SA (ALM.MC) Chart
Key Statistics of Almirall SA (ALM.MC)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€12.44Volume
130.96KP/E Ratio (TTM)
56.1052 Week Range
Market Cap
2.64BAvg. Volume
132.32KDividend Yield
1.01%Financial Metrics & Statements of Almirall SA (ALM.MC)
FAQ's for Almirall SA (ALM.MC)
- According to Musaffa’s Shariah screening methodology, Almirall SA (ALM.MC) is currently classified as HALAL as of March 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.